Skip to main content

Table 1 Sample demographics divided by subgroups and analysis stage

From: Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients

Group

N

Age

Gender

Chest radiographic

Smoking

Median (Range)

M/F

Stage 0/I/II/III/IV

Non/Ex/Current

Discovery

     

Asthma

17

22 (18–52)

6/11

NA

17/0/0

Control

16

24 (20–56)

8/8

NA

14/2/0

Löfgren’s syndrome

18

41 (30–57)

12/6

1a/8/9/0/0

11/5/2

Non-Löfgren’s syndrome

17

47 (29–67)

10/7

1a/5/8/1/2

6/8/3

Verification

     

Control

33

25 (18–56)

18/17

NA

32/1/0

Löfgren’s syndrome

112

37 (23–62)

59/53

2a/72/38/0/0

60/33/18

Non-Löfgren’s syndrome

104

44 (26–77)

63/41

5/41/40/14/4

63/30/11

  1. Complete information was not available for all patients
  2. NA not applicable
  3. aPatients had previously manifested lymphadenopathy, though determined to have fully regressed on conventional x-ray at the time of bronchoscopy